-
Baxter One Of Several Firms Said To Be Exploring An Acquisition Of India-Based Gland Pharma
Friday, April 15, 2016 - 11:12am | 247Read More...According to a report by Reuters, Baxter International Inc (NYSE: BAX) is among one of several players that are eyeing an acquisition of India-based Gland Pharma. Reuters, citing "three people with direct knowledge of the matter," added that Advent International and Indian drugmaker...
-
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Thursday, July 3, 2014 - 10:36am | 873Read More...Cowen analysts recently released a research report that focused on biotech stocks with promising Phase 3 data leading into the U.S. Food and Drug Administration (FDA) approval process. ACADIA Pharmaceuticals (NASDAQ: ACAD), Alexion Pharmaceuticals (NASDAQ: ALXN), InterMune (NASDAQ: ITMN) and...
-
Rethink Robotics CEO Scott Eckert Promotes Manufacturing Robot Baxter
Thursday, June 27, 2013 - 12:40pm | 520Read More...Rethink Robotics President and CEO Scott Eckert wants to help return manufacturing jobs to the United States from overseas by introducing an automated robot into manufacturing plants. His name is Baxter. He appeared on CNBC's Squawk Box on Thursday morning to talk about the robot. "Baxter is in...
-
Illumina and Other Bargain Biotech Stocks Worth a Look Now
Wednesday, May 1, 2013 - 12:57pm | 916Read More...The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list include Endo Health Solutions (NASDAQ: ENDP), Illumina (NASDAQ: ILMN) and Keryx Biopharmaceuticals (...
-
Are Scientists Edging Closer to a Cure for Alzheimer's?
Monday, March 11, 2013 - 8:58am | 489Read More...A recent Australian study points toward possible good news in the search for answers regarding Alzheimer’s disease. The Border Mail reports that Australians will be among the first to test new drugs hoped to ward off Alzheimer’s after researchers discovered that the illness takes decades to...
-
A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD)
Sunday, December 9, 2012 - 12:17am | 631Read More...Three of Fortune's top 10 stock picks for 2013 are health care related companies. But they are not in big names in the sector, such as Johnson & Johnson (NYSE: JNJ) or Pfizer (NYSE: PFE). They were Align Technology (NASDAQ: ALGN), Fresenius Medical Care (NYSE: FMS) and Gilead Sciences (NASDAQ:...
-
Seven Hot Chinese Stocks
Tuesday, February 14, 2012 - 7:37am | 1010Read More...Vice President Xi Jinping of China meets with President Obama on Tuesday at the White House in an effort to enhance trust between the two countries. And here is a quick look at some Chinese stocks that have risen between 15% and 25% year to date. They all are traded on U.S. exchanges, and each pays...
-
JP Morgan Comments on Trial Completion of Baxter's Alzheimer's Drug
Thursday, July 14, 2011 - 7:35am | 112Read More...“We confirmed on Wednesday that the first of Baxter's (NYSE: BAX) two phase III IVIG for Alzheimer's trials has now completed enrollment,” JP Morgan wrote in a report this morning. “An additional 30 patients were enrolled in the trial versus plan bringing total enrollment to 390 patients...
-
ISI Provides Color on Biogen Idec
Wednesday, July 13, 2011 - 3:29am | 99Read More...ISI provided color on Biogen Idec (NASDAQ: BIIB). In a research report published today, ISI is optimistic about the company's new drug, which has the potential of outperforming its competitors. In the report, ISI states, “Abstracts for the ISTH meeting are out. For BIIB, the most important is the...
-
Morgan Keegan's Favorite Ideas in the Hospital Supplies Group: Baxter, Covidien, and Hill-Rom
Tuesday, July 12, 2011 - 8:49am | 150Read More...Calendar second-quarter earnings for the hospital supplies group are scheduled to kick-off on July 19th, Morgan Keegan reports. “Going into earnings, our favorite long ideas are Outperform rated Baxter (NYSE: BAX) ($70 PT) and Covidien (NYSE: COV) ($63 PT), and Market Perform rated Hill-Rom...
-
Goldman Sachs Raises Baxter Target from $69 to $72
Tuesday, May 31, 2011 - 7:28am | 28Read More...Goldman Sachs is raising its PT on shares of Baxter International Inc. (NYSE: BAX) from $69 to $72. Baxter closed Friday at $59.11.
-
Medtronic Down But Not Out (MDT, BAX, STJ)
Tuesday, October 5, 2010 - 8:25pm | 319Read More...Medtronic (NYSE: MDT) is down for the year, but not out. While the S&P 500 has staged a mighty rally over the past 5 weeks bringing the index solidly into positive territory for the year (up 5.9% including dividends as of October 5th) Medtronic has fallen 22.8%. MDT is the world's largest...
-
Deutsche Bank Initiations For 9/10
Friday, September 10, 2010 - 8:34am | 219Read More...Initiation coverage from Deutsche Bank for September 10 is as follows: St. Jude Medical (NYSE: STJ) Initiate with Hold Rating and $39 price target Boston Scientific (NYSE: BSX) Initiate with Hold rating and $6.30 price target. Zimmer Holdings (NYSE: ZMH) Initiate with Hold rating and $53 price...
-
Deutsche Bank Initiations For 9/10
Friday, September 10, 2010 - 8:33am | 209Read More...St. Jude Medical (NYSE: STJ) Initiate with Hold Rating and $39 price target Boston Scientific (NYSE: BSX) Initiate with Hold rating and $6.30 price target. Zimmer Holdings (NYSE: ZMH) Initiate with Hold rating and $53 price target CareFusion Corporation (NYSE: CFN) Initiate with Hold rating and $23...
